Identification of highly conserved domains in hemagglutinin associated with the receptor binding specificity of influenza viruses: 2009 H1N1, avian H5N1, and swine H1N2

Wei Hu
DOI: 10.4236/jbise.2010.32017                

Abstract

The hemagglutinin (HA) of influenza viruses facilitates receptor binding and membrane fusion, which is the initial step of virus infection. Human influenza viruses preferentially bind to receptors with α2-6 lin- kages to galactose (SAα2,6Gal), whereas avian influenza viruses prefer receptors with α2-3 linkages to galactose (SAα2,3Gal). The current 2009 H1N1 pandemic is caused by a novel influenza A virus that has its genetic materials from birds, humans, and pigs. Its pandemic nature is characterized clearly by its dual binding to the α2-3 as well as α2-6 receptors, because the seasonal human H1N1 virus only binds to the α2-6 receptor. In a previous study, the informational spectrum method (ISM), a bioinformatics technique, was applied to uncover one highly conserved region in the HA protein associated with receptor binding preference in each of various influenza subtypes. In the present study, we extended the previous work by discovering multiple such domains in HA of 2009 H1N1 and avian H5N1 to expand our repertoire of known key regions in HA responsible for receptor binding affinity. Three such domains in HA of 2009 H1N1 were found at residue positions 106 to 130, 150 to 174, and 191 to 221, and another three domains in HA of avian H5N1 were located at residue positions 46 to 65, 136 to 153, and 269 to 286. These identified domains could be utilized as therapeutic and diagnostic targets for the prevention and treatment of influenza infection.

Keywords

Binding Specificity; Discrete Fourier Transform; Electron-Ion Interaction Potential; Entropy; Hemagglutinin; Influenza; Informational Spectrum Method

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Alexandra, G., Alexander, T., Galina, P., Nicolai, B., A- manda, B. and Alexander, K. (2006) Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology, 344, 432-438.
[2]	Tatsunori, I., Kaori, F., Katsuhisa, N., Sachiko, A.H., Yuji, M., Hirofumi, W. and Shigenori, T. (2008) Theoretical a- nalysis of binding specificity of influenza viral hemagglutinin to avian and human receptors based on the fragment molecular orbital method. Computational Biology and Chemistry, 32, 198-211.
[3]	Shinya, Y., Yasuo, S., Takashi, S., Mai, Q.L., Chairul, A. N.S., Yuko, T., Yukiko, M. et al. (2006) Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature, 444(7117), 378-82.
[4]	Venkataramanan, S., Kannan, T., Rahul, R., Raguram, S., Zachary, S., Sasisekharan, V. and Ram, S. (2009) Extra- polating from sequence—the 2009 H1N1 “swine” influenza virus. Nature Biotechnology, 27, 510-513.
[5]	Robert, A.C., Angelina, S.P., Steve, W., Tatyana, M., Liu, Y., Chai, W., Maria, A.C.R., Zhang, Y., Markus, E., Ma- koto, K., Alan, H., Mikhail, M. and Ten, F. (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nature Biotechnology, 27, 797-799.
[6]	Hu, W. (2009) Analysis of correlated mutations, stalk mo- tifs, and phylogenetic relationship of the 2009 influenza a virus neuraminidase sequences. Journal of Biomedical Science and Engineering, 2(7), 550-558.
[7]	Hu, W. (2010) The interaction between the 2009 H1N1 influenza a hemagglutinin and neuraminidase: Mutations, co-mutations, and the NA stalk motifs. Journal of Biomedical Science and Engineering, 3, 1–12.
[8]	Cosic, I. (1997) The resonant recognition model of macromolecular bioreactivity—theory and application. Birkhauser Verlag, Berlin.
[9]	Veljkovic, V. and Metlas, R. (1988) Identification of na- nopeptide from HTLV3, LAV and ARV-2 envelope gp120 determining binding to T4 cell surface protein. Cancer Biochem Biophys, 10, 91-106.
[10]	Veljkovic, V., Veljkovic, N., Este, J.A., Huther, A. and ietrich, D.U. (2007) Application of the EIIP/ISM bioinformatics concept in development of new drugs. Curr Med Chem, 14, 441-453.
[11]	Veljkovic, V., Veljkovic, N. and Metlas, R. (2004) Molecular makeup of HIV-1 envelope protein. Int Rev Immunol, 23, 383-411.
[12]	Veljkovic, V., Niman, H.L., Glisic, S., Veljkovic, N., Pero- vic, V. and Muller, C.P. (2009) Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor. BMC Structural Biology, 9, 62.
[13]	Veljkovic, V., Veljkovic, N., Muller, C.P., Müller, S., Gli- sic, S., Perovic, V. and K?hler, H. (2009) Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: Possible consequences for therapy and infection control. BMC Struct Biol, 7, 9-21.
[14]	Katoh, K., Kuma, K., Toh, H. and Miyata, T. (2005) M- AFFT version 5: Improvement in accuracy of multiple sequence alignment. Nucleic Acids Res, 33, 511-518.
[15]	MacKay, D. (2003) Information theory, inference, and learning algorithms. Cambridge University Press.
[16]	KováccaronOVá, A., Ruttkay-Nedecky, G., HaverlíK, I. K. and Janecccaronek, S. (2002) Sequence similarities and evolutionary relationships of influenza virus a hemagglutinins. Virus Genes, 24, 57-63.
[17]	Gamblin, S.J., Haire, L.F., Russell, R.J., Stevens, D.J., Xiao, B., Ha, Y. et al. (2004) The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science, 303, 1838-1842.
[18]	Michael, W.D. and Pan, K. (2009) The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. Protein Engineering, Design & Selection, 22, 543- 546.
[19]	Du, A., Daidoji, T., Koma, T., Ibrahim, M.S., Nakamura, S., de Silva, U.C., Ueda, M., Yang, C.S., Yasunaga, T., Ikutu, K. and Nakaya, T. (2009) Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody. Biochem Biophys Res Commun, 378, 197-202.
[20]	Kaverin, N.V., Rudneva, I.A., Govorkova, E.A., Timo- feeva, T.A., Shilov, A.A., Kochergin-Nikitsky, K.S., Kry- lov, P.S. and Webster, R.G. (2007) Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol., 81, 12911-12917.
[21]	Yang, M., Clavijo, A., Graham, J., Salo, T., Hole, K., Berhane, Y. (2009) Production and diagnostic application of monoclonal antibodies against influenza virus H5, J Virol Methods, 162, 194-202.